Evidence map›Paper›PMID 36011317›Full record

ArticleGenes2022

Prediction of Alzheimer's Disease by a Novel Image-Based Representation of Gene Expression.

Habil Kalkan, Umit Murat Akkaya, Güldal Inal-Gültekin, Ana Maria Sanchez-Perez

Abstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Habil KalkanDepartment of Computer Engineering, Gebze Technical University, 41400 Kocaeli, Turkey.ORCID 0000-0002-5456-8385
Umit Murat AkkayaDepartment of Computer Engineering, Gebze Technical University, 41400 Kocaeli, Turkey.
Güldal Inal-GültekinDepartment of Physiology, Faculty of Medicine, Istanbul Okan University, 34959 Istanbul, Turkey.
Ana Maria Sanchez-PerezFaculty of Health Science and Institute of Advanced Materials (INAM), University Jaume I, 12071 Castellon, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early intervention can delay the progress of Alzheimer's Disease (AD), but currently, there are no effective prediction tools. The goal of this study is to generate a reliable artificial intelligence (AI) model capable of detecting the high risk of AD, based on gene expression arrays from blood samples. To that end, a novel image-formation method is proposed to transform single-dimension gene expressions into a discriminative 2-dimensional (2D) image to use convolutional neural networks (CNNs) for classification. Three publicly available datasets were pooled, and a total of 11,618 common genes' expression values were obtained. The genes were then categorized for their discriminating power using the Fisher distance (AD vs. control (CTL)) and mapped to a 2D image by linear discriminant analysis (LDA). Then, a six-layer CNN model with 292,493 parameters were used for classification. An accuracy of 0.842 and an area under curve (AUC) of 0.875 were achieved for the AD vs. CTL classification. The proposed method obtained higher accuracy and AUC compared with other reported methods. The conversion to 2D in CNN offers a unique advantage for improving accuracy and can be easily transferred to the clinic to drastically improve AD (or any disease) early detection.

Indexed as

Alzheimer DiseaseCognitive DysfunctionArtificial IntelligenceGene ExpressionHumansMagnetic Resonance Imagingdeep learningdementialocal discriminant analysismild cognitive impairment

Identifiers

PMID36011317
PMCPMC9407775

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.